Insights

In the multi-trillion-dollar pharmaceutical industry, there’s an attic. It’s filled not with dust and forgotten relics, but with something far […]

Day one of generic competition is the moment most specialty pharmacies dread. The brand rep stops calling. The PBM’s preferred

When Pfizer launched atorvastatin (Lipitor) in 1997, it did not simply sell a cholesterol drug. It built, over the next

Introduction: The Allure of the Biotech Lottery: Beyond the Hype Scan the financial headlines on any given day, and you’re

In the spring of 2014, a small biotech called Idenix Pharmaceuticals held patents covering certain nucleotide analogue structures with antiviral

How Drug Patent LOE forecasting gives equipment suppliers a 24-month head start on their competitors Every year, branded pharmaceutical companies

The Question Nobody Answers Clearly Ask a pharmaceutical executive how long a drug patent lasts in Latin America and you

The Number Everyone Quotes Is Wrong Twenty years. Ask anyone in the pharmaceutical industry how long a drug patent lasts,

There is a predictable moment in generic drug manufacturing when a company’s capital expenditure committee approves a granulation line that